Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-11-084022
Filing Date
2011-03-31
Accepted
2011-03-31 09:16:52
Documents
7
Period of Report
2011-03-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d6k.htm 6-K 12765
2 ANNUAL INFORMATION FORM, DATED MARCH 30, 2011 dex991.htm EX-99.1 335248
3 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION dex992.htm EX-99.2 241390
4 CONSOLIDATED FINANCIAL STATEMENTS dex993.htm EX-99.3 487026
5 FORM 52-109F1 - CERTIFICATION OF ANNUAL FILINGS, DATED MARCH 30, 2011 dex994.htm EX-99.4 8104
6 FORM 52-109F1 - CERTIFICATION OF ANNUAL FILINGS, DATED MARCH 30, 2011 dex995.htm EX-99.5 8111
7 GRAPHIC g166927g55l78.jpg GRAPHIC 86934
  Complete submission text file 0001193125-11-084022.txt   1213556
Mailing Address 200-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 200-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
TEKMIRA PHARMACEUTICALS CORP (Filer) CIK: 0001447028 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-34949 | Film No.: 11723940
SIC: 2834 Pharmaceutical Preparations